Best Cancer Pharma stock in India 2024 to keep an eye on!
Trade Brains
SEPTEMBER 15, 2024
Financially, Beta Drugs saw strong growth with revenue rising from ₹227 crore in 2023 to ₹296 crore in 2024. Its net profit also increased from ₹31 crore in 2023 to ₹36 crore in 2024, reflecting its expanding market presence. The company’s API business shows a diverse portfolio in FY24. Current Market Price ₹ 843.1
Let's personalize your content